Evidence map›Paper›PMID 36826115›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States.

Thomas Seisen, Muhieddine Labban, Stuart R Lipsitz, Mark A Preston, Matthew Mossanen, Joaquim Bellmunt, Morgan Rouprêt, Toni K Choueiri, Adam S Kibel, Maxine Sun and 1 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Thomas SeisenDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Muhieddine LabbanDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Stuart R LipsitzCenter for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
Mark A PrestonDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Matthew MossanenDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Joaquim BellmuntLank Center for Genitourinary Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02115, USA.
Morgan RouprêtDepartment of Urology, Pitié-Salpêtrière Hospital, APHP, Sorbonne University, GRC n°5 Predictive Onco-Urology, 75013 Paris, France.
Toni K ChoueiriLank Center for Genitourinary Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02115, USA.
Adam S KibelDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Maxine SunLank Center for Genitourinary Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02115, USA.
Quoc-Dien TrinhDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
Treating the P13-Kinase/AKTP50CA101942 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI David McDermott · 2003 to 2026
$53.4M
NCI NIH HHS P30 CA006516NCI NIH HHS P50 CA101942
6 · The paper itself

Abstract

backgroundSince tobacco smoking represents the most established risk factor for bladder cancer, we sought to assess the ecological association between tobacco smoking prevalence and bladder cancer incidence and to contrast it with lung cancer.

methodsThe annual overall tobacco smoking prevalence rates were extracted from the Report of the Surgeon General and the Center for Disease Control between 1953 and 1983. The overall age-adjusted incidence rates for bladder and lung cancers were derived from the Surveillance, Epidemiology, and End Results database between 1983 and 2013 (30-year latency period). Weighted least square regression models were used to assess bladder and lung cancer incidence rate differences (IRD) related to trends in tobacco smoking prevalence. A Wald test was used to compare whether the prevalence of tobacco smoking, as an explanatory variable, differentially predicts bladder versus lung cancer incidence rates.

resultsThe associations between tobacco smoking prevalence and bladder cancer incidence were not significant in the overall (IRD = +0.04; 95%CI (-0.14; +0.22);

conclusionsVariations in tobacco smoking prevalence only partially explained the trends in the incidence of bladder cancer, indicating that its etiology is complex.

Indexed as

Lung NeoplasmsUrinary Bladder NeoplasmsFemaleHumansIncidenceMaleSEER ProgramSmokingTobacco SmokingUnited Statesepidemiologyincidencelung neoplasmsprevalencesmokingtobaccourinary bladder neoplasms

Identifiers

PMID36826115
PMCPMC9954867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.